NOT KNOWN FACTS ABOUT IL-2 THERAPY FOR MELANOMA

= 0.06) when compared Using the IL-two group. These scientific tests illustrated the addition of cytokines could boost the effect of vaccine therapy in patients with melanoma and highlighted the prospective of working with rational combinations of immune brokers in treating individuals with metastatic cancer.From the literature, we could also find